Sun Pharma inks distribution alliance with Mitsubishi Tanabe
New Delhi:Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from Swiss drug firm Novartis in Japan, earlier this year for USD 293 million.
Sep 06, 2016, 11:33 AM ISTNovartis Japan unit charged over research manipulation
In April, Novartis replaced the top executives at its Japanese arm over those allegations.
Jul 01, 2014, 15:16 PM IST